Robert B. Catell, Director at BioRestorative Therapies, Inc. (BRTX), bought 12,500 shares at $4.00 ($50K) on 2016-05-18, disclosed to the SEC on 2016-05-19.
Open-market purchase of $50k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |